New Data Support Incorporating Crenolanib Into Salvage… : Oncology Times
A randomized, phase III clinical trial conducted has demonstrated that the addition of crenolanib to salvage chemotherapy significantly improves outcomes in adults with AML harboring FLT3 mutations.
